Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
180 participants
INTERVENTIONAL
2025-10-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of a Discharge Sock Model in Comfort: Randomized Controlled Trial
NCT04697914
Flexible Footwear and Insole in Heel Pain
NCT03040557
Effectiveness of Four Orthotic Insoles on Pain in the Lower Body Associated With Musculoskeletal Stress
NCT04746755
Effects of Prefabricated Foot Orthoses With and Without Metatarsal Pads on Central Metatarsalgia
NCT06350435
A Test of Efficacy and Foot Position Alteration in Patients Wearing Good Feet Arch Supports for the Treatment of Pain
NCT07103070
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Socks
The intervention will be the daily use of socks with the integration of the customized orthotic element.
Socks
Plantar orthotic elements will be designed, according to the participants' previous baropodometric pattern, to alleviate pathological plantar pressure. These elements will be integrated into commonly worn items by patients, such as stockings or socks.
Standard device
The intervention will be the daily use of external orthotic elements (to be put on and taken off daily) and of standard manufacture.
Standard device
Removable device of digital alignment to stabilize and unload the affected metatarsophalangeal joint. They do not require frequent replacement as they are washable and reusable elements.
Foot orthoses
The participants will receive completely personalized plantar supports integrating the relief element.
Foot orthoses
Custom-made foot orthoses.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Socks
Plantar orthotic elements will be designed, according to the participants' previous baropodometric pattern, to alleviate pathological plantar pressure. These elements will be integrated into commonly worn items by patients, such as stockings or socks.
Standard device
Removable device of digital alignment to stabilize and unload the affected metatarsophalangeal joint. They do not require frequent replacement as they are washable and reusable elements.
Foot orthoses
Custom-made foot orthoses.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 55 years;
* Experiencing moderate to severe pain in the plantar area of the forefoot;
* Presenting hyperkeratosis under the central metatarsal heads;
* Presenting pre-dislocation syndrome of the second or third metatarsophalangeal joint.
Exclusion Criteria
* Have undergone previous osteoarticular surgeries on the feet;
* Diagnosis of rheumatoid arthritis with involvement in the metatarsophalangeal joints of the foot;
* Present symptoms compatible with Morton's neuritis;
* Use of walking aids;
* Are under treatment with insoles;
* Refuse the use of designated socks or plantar supports during the follow-up period.
55 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Seville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pedro V. Munuera-Martínez
Principal Investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N2009020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.